Home | Back to newsletter main page
 |
|
July 6, 2010 |
|
MESSAGE FROM THE DIRECTORCase CCC Retreat: Thinking of Cancer as a Disease, Not a Cell LineThe focus of this year's retreat is on translational cancer research with a bias towards disease-based research efforts and cancer cohorts. We will feature a few new initiatives this year that are priorities for the Cancer Center. These reflect trends developing in funding efforts for the National Cancer Institute. First, the trends coming out of NCI include an interest in focusing our basic research efforts towards identifying targets that may be useful for new drug development, understanding individual cancer susceptibility to specific cancer treatments or using pathways, genomics and other phenotypic characterizations for cancer risk prediction, prognosis and response to experimental as well as conventional treatments. Presentations by new investigators recruited in the past year will start the program, followed by a luncheon breakout session for each Program to discuss "hot" science, and to consider the strategic direction of the Program. This will be followed by research presentations from the Cancer Signaling, Cancer Imaging, Cell Death Pathways, and Prevention and Control Programs. We will use this to prioritize resources, recruitment and program development to help us develop an overall strategic plan for the Cancer Center. We will continue to put resources into multi-investigator efforts in disease areas to encourage development of larger "team" science in cancer research. Reflecting this, we will have presentations on use of tissue-based research using biorepositories and the use of large cohorts for gene discovery. Derek Raghavan, MD, PhD, will lead a discussion on Saturday morning on the recent experience from study section, with 4 of our members who sit on grant review committees who will comment on the new 12-page grant and how they are reviewed under the new review format. This will be invaluable for all of us submitting grants in the next year. Our program includes 73 abstracts from trainees with viewing time throughout the retreat and after dinner poster discussions and evaluation with the 8-9 awards for outstanding posters. I would like to thank the hard work of the Cancer Center administrative staff and the exceptional effort of the Retreat Planning Committee: Drs. Jill Barnholtz-Sloan, Greg Cooper, David Danielpour, Chris Flask, Ram Ganapathi, Candece Gladson, Danny Manor, Nathan Pennell, John Pink, and Zhenghe Wang. See you at the retreat! Stan Gerson, MD ANNOUNCEMENTS2010 Ohio Cancer Research Associates Grant AwardeesCongratulations to the following Cancer Center Member recipients of 2010 Ohio Cancer Research Associates grant awards! Barbara Bedogni, PhD [Skin Cancer] David Wald, MD, PhD [Leukemia] Scott Welford, PhD [Radiation Oncology] NEW FUNDING OPPORTUNITIESASCO Cancer Foundation Improving Cancer Care Grant, funded by Susan G. Komen for the CureThe ASCO Cancer Foundation® Improving Cancer Care Grant, funded by Susan G. Komen for the Cure®, will provide extramural research funding to address important issues regarding access to healthcare, quality of care, and delivery of care, with general applicability to breast cancer. The goal of this program is to encourage multi-disciplinary research that will have a major impact on cancer care, with general applicability in the breast cancer arena. This grant opportunity is part of the Susan G. Komen for the Cure/ASCO Cancer Foundation Research Initiative. Required LOI Deadline: September 1 |
EVENTS
**All events are open to anyone interested in attending July 5July 6July 7Grand Rounds will resume July 14 July 8July 9Taussig Cancer Institute Grand Rounds will resume September 10 Cancer Center Research in Progress Seminar will resume in September Case CCC Scientific Retreat July 10Case CCC Scientific Retreat
For a complete listing of LRI seminars click here. UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSCancer Center Scientific Series Cancer Center Scientific Series ADDITIONAL UPCOMING SEMINARS & EVENTSBusiness Education Course: "The Business of Regenerative Medicine: From Stem Cells to the Market Place" Advanced Training Institute on Health Behavior Theory 2010 caBIG Annual Meeting: Building a Collaborative Biomedical Network Oncology Congress International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer |
ACS IRG PILOT FUNDINGAmerican Cancer Society-Case Comprehensive Cancer Center Pilot Project Funding OpportunityPilot funding is available for cancer-related research in basic, clinical, prevention & control, behavioral, health services and epidemiology. Instructions, frequently asked questions, and applications available at http://cancer.case.edu. For more information, please contact Terri Daso, Cancer Center Administration, 844-7252, tld6@case.edu. Eligibility: Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application. Letter of Intent Deadline: Monday, July 26 |
|
NCI CANCER BULLETINFeatured Article Cancer Research Highlights Guest Director's Update: Dr. Julia H. Rowland, Director, NCI Office of Cancer Survivorship |
|
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
|
|
DOD PRCRP Idea Awards |
DOD Peer Reviewed Cancer Research Program (PRCRP) Idea Awards |
NIH BULLETIN – Notices and Funding OpportunitiesAdvancing Novel Science in Womens Health Research (ANSWHR) (R21) (PAS-10-226) |
|
|
Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| |